Literature DB >> 31475837

Diagnosis of pre-sarcopenia from a single selectional crosscut at C3 region, using CT scans before radiotherapy.

Bianca Tabita Muresan1, Carlos Sánchez Juan1, Ana Artero1, Ana Hernández Machancoses2, Piedad Almendros-Blanco2, Alegría Montoro3, Gonzalo Sánchez Jordá4, Cristian Marco-Alacid1, Jaime Ríos Ríos5, José Miguel Soriano Del Castillo6, Laura Sánchez Guillén7, José López-Torrecilla2.   

Abstract

INTRODUCTION: Purpose: the main purpose of this study was to diagnose pre-sarcopenia in cancer patients who had lack of computed tomography (CT) abdominal images, with a newly discovered method based on cervical images. Material and methods: a sample of 37 patients with either lung cancer or a cancer that affected the upper digestive system underwent radiotherapy computed simulation which included measurements at C3 and L3 regions. Skeletal muscle mass (SMM) and skeletal muscle index (SMI) were determined by Hounsfield units and compared in both regions. Pre-sarcopenia was identified according to the cut-points currently established: ≤ 41 cm2/m2 in females, ≤ 43 cm2/m2 in males with a BMI ≤ 25 kg/m2, and ≤ 53 cm2/m2 in males with a BMI > 25 kg/m2.
Results: the correlation of SMM and SMI between the C3 and L3 regions was R2 = 0.876 and R2 = 0.805, respectively. Moreover, there was a positive association (86.49%) in terms of the diagnosis of pre-sarcopenia according to both regions. In total, eleven pre-sarcopenic patients (29.37%) were identified; three of them being overweight (27.27%) and two of them being obese (18.18%).
Conclusion: a single sectional cross at the level of C3 can be used for the diagnosis of pre-sarcopenia. This new method avoids unnecessary irradiation, saves hospital costs and detects malnutrition before starting radiotherapy treatment in cancer patients who have lack of CT abdominal imaging.

Entities:  

Keywords:  Tomografía computarizada. Sarcopenia. Radioterapia. Cáncer.

Mesh:

Year:  2019        PMID: 31475837     DOI: 10.20960/nh.02422

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  2 in total

1.  Establishment and Validation of Pre-Therapy Cervical Vertebrae Muscle Quantification as a Prognostic Marker of Sarcopenia in Patients With Head and Neck Cancer.

Authors:  Brennan Olson; Jared Edwards; Catherine Degnin; Nicole Santucci; Michelle Buncke; Jeffrey Hu; Yiyi Chen; Clifton D Fuller; Mathew Geltzeiler; Aaron J Grossberg; Daniel Clayburgh
Journal:  Front Oncol       Date:  2022-02-14       Impact factor: 5.738

2.  The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer.

Authors:  Belinda Vangelov; Judith Bauer; Daniel Moses; Robert Smee
Journal:  Head Neck       Date:  2022-02-09       Impact factor: 3.821

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.